Germline DNA copy number variation in familial and early-onset breast cancer

Breast Cancer Research

Volumn 14, Issue 1, 2012, Pages

  Krepischi, Ana C V ^a,b   Achatz, Maria Isabel W ^a,b   Santos, Erika M M ^a   Costa, Silvia S ^b   Lisboa, Bianca C G ^a   Brentani, Helena ^b   Santos, Tiago M ^a   Gonçalves, Amanda ^a   Nóbrega, Amanda F ^a   Pearson, Peter L ^b   Vianna Morgante, Angela M ^b   Carraro, Dirce M ^a,b   Brentani, Ricardo R ^a,b   Rosenberg, Carla ^b  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; EARLY ONSET BREAST CANCER; FAMILIAL BREAST CANCER; FAMILIAL CANCER; FEMALE; GENE DELETION; GENE DUPLICATION; GENETIC ASSOCIATION; GENOME; HUMAN; MAJOR CLINICAL STUDY; AGED; CASE CONTROL STUDY; COHORT ANALYSIS; DNA MICROARRAY; GENE DOSAGE; GENETICS; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; MIDDLE AGED; MUTATION; NONPARAMETRIC TEST; PAGET NIPPLE DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; COHORT STUDIES; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GENE DOSAGE; GERM-LINE MUTATION; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84856577365     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3109     Document Type: Article

References (45)

1. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997, 278:1043-1050. 10.1126/science.278.5340.1043, 9353177.
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343:78-85. 10.1056/NEJM200007133430201, 10891514.
3. Chompret A. [Clinical and molecular diagnosis of inherited breast-ovarian cancer] [in French]. J Gynecol Obstet Biol Reprod (Paris) 2003, 32:101-119.
4. Easton D. Familial risks of cancer. Eur J Cancer 1999, 35:1043-1045.
5. Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med 2008, 359:2143-2153. 10.1056/NEJMra0802968, 19005198.
6. Hirshfield KM, Rebbeck TR, Levine AJ. Germline mutations and polymorphisms in the origins of cancers in women. J Oncol 2010, 2010:297671. 2810468, 20111735.
7. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes C, Campbell P, Fitzgerald T, Hu M, Ihm CH, Kristiansson K, Macarthur DG, MacDonald JR, Onyiah I, Pang AW, Robson S, Stirrups K, Valsesia A, Walter K, Wei J, , Tyler-Smith C, Carter NP, Lee C, Scherer SW, Hurles ME. Wellcome Trust Case Control Consortium Origins and functional impact of copy number variation in the human genome. Nature 2010, 464:704-712. 10.1038/nature08516, 19812545, Wellcome Trust Case Control Consortium.
8. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C. Detection of large-scale variation in the human genome. Nat Genet 2004, 36:949-951. 10.1038/ng1416, 15286789.
9. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Månér S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528. 10.1126/science.1098918, 15273396.
10. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006, 7:85-97.
11. Ng PC, Levy S, Huang J, Stockwell TB, Walenz BP, Li K, Axelrod N, Busam DA, Strausberg RL, Venter JC. Genetic variation in an individual human exome. PLoS Genet 2008, 4:e1000160. 10.1371/journal.pgen.1000160, 2493042, 18704161.
12. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med 2010, 61:437-455. 10.1146/annurev-med-100708-204735, 20059347.
13. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, Tyler-Smith C, Carter N, Scherer SW, Tavaré S, Deloukas P, Hurles ME, Dermitzakis ET. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007, 315:848-853. 10.1126/science.1136678, 2665772, 17289997.
14. Bunyan DJ, Eccles DM, Sillibourne J, Wilkins E, Thomas NS, Shea-Simonds J, Duncan PJ, Curtis CE, Robinson DO, Harvey JF, Cross NC. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 2004, 91:1155-1159. 10.1038/sj.bjc.6602121, 2747696, 15475941.
15. Casilli F, Tournier I, Sinilnikova OM, Coulet F, Soubrier F, Houdayer C, Hardouin A, Berthet P, Sobol H, Bourdon V, Muller D, Fricker JP, Capoulade-Metay C, Chompret A, Nogues C, Mazoyer S, Chappuis P, Maillet P, Philippe C, Lortholary A, Gesta P, Bézieau S, Toulas C, Gladieff L, Maugard CM, Provencher DM, Dugast C, Delvincourt C, Nguyen TD, Faivre L, et al. The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 2006, 43:e49. 10.1136/jmg.2005.040212, 16950820.
16. Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drüsedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van 't Veer LJ, Bakker E, van Ommen GJ, Devilee P. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997, 17:341-345. 10.1038/ng1197-341, 9354803.
17. Kuiper RP, Ligtenberg MJ, Hoogerbrugge N, Geurts van Kessel A. Germline copy number variation and cancer risk. Curr Opin Genet Dev 2010, 20:282-289. 10.1016/j.gde.2010.03.005, 20381334.
18. Shlien A, Baskin B, Achatz MI, Stavropoulos DJ, Nichols KE, Hudgins L, Morel CF, Adam MP, Zhukova N, Rotin L, Novokmet A, Druker H, Shago M, Ray PN, Hainaut P, Malkin D. A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes. Am J Hum Genet 2010, 87:631-642. 10.1016/j.ajhg.2010.10.007, 2978979, 21056402.
19. Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K, Mossé YP, Wood A, Lynch JE, Pecor K, Diamond M, Winter C, Wang K, Kim C, Geiger EA, McGrady PW, Blakemore AI, London WB, Shaikh TH, Bradfield J, Grant SF, Li H, Devoto M, Rappaport ER, Hakonarson H, Maris JM. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 2009, 459:987-991. 10.1038/nature08035, 2755253, 19536264.
20. Liu W, Sun J, Li G, Zhu Y, Zhang S, Kim ST, Sun J, Wiklund F, Wiley K, Isaacs SD, Stattin P, Xu J, Duggan D, Carpten JD, Isaacs WB, Grönberg H, Zheng SL, Chang BL. Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res 2009, 69:2176-2179. 10.1158/0008-5472.CAN-08-3151, 2743179, 19258504.
21. Lucito R, Suresh S, Walter K, Pandey A, Lakshmi B, Krasnitz A, Sebat J, Wigler M, Klein AP, Brune K, Palmisano E, Maitra A, Goggins M, Hruban RH. Copy-number variants in patients with a strong family history of pancreatic cancer. Cancer Biol Ther 2007, 6:1592-1599. 10.4161/cbt.6.10.4725, 17912030.
22. Thean LF, Loi C, Ho KS, Koh PK, Eu KW, Cheah PY. Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients. Genes Chromosomes Cancer 2010, 49:99-106.
23. Venkatachalam R, Verwiel ET, Kamping EJ, Hoenselaar E, Görgens H, Schackert HK, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N, van Kessel AG, Kuiper RP. Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. Int J Cancer 2011, 129:1635-1642. 10.1002/ijc.25821, 21128281.
24. Yoshihara K, Tajima A, Adachi S, Quan J, Sekine M, Kase H, Yahata T, Inoue I, Tanaka K. Germline copy number variations in BRCA1-associated ovarian cancer patients. Genes Chromosomes Cancer 2011, 50:167-177. 10.1002/gcc.20841, 21213370.
25. National Comprehensive Cancer Network. , http://www.nccn.org/
26. Krepischi-Santos AC, Rajan D, Temple IK, Shrubb V, Crolla JA, Huang S, Beal S, Otto PA, Carter NP, Vianna-Morgante AM, Rosenberg C. Constitutional haploinsufficiency of tumor suppressor genes in mentally retarded patients with microdeletions in 17p13.1. Cytogenet Genome Res 2009, 125:1-7. 10.1159/000218743, 2813804, 19617690.
27. Krepischi AC, Knijnenburg J, Bertola DR, Kim CA, Pearson PL, Bijlsma E, Szuhai K, Kok F, Vianna-Morgante AM, Rosenberg C. Two distinct regions in 2q24.2-q24.3 associated with idiopathic epilepsy. Epilepsia 2010, 51:2457-2460. 10.1111/j.1528-1167.2010.02742.x, 21204806.
28. Allemeersch J, Van Vooren S, Hannes F, De Moor B, Vermeesch JR, Moreau Y. An experimental loop design for the detection of constitutional chromosomal aberrations by array CGH. BMC Bioinformatics 2009, 10:380. 10.1186/1471-2105-10-380, 2791104, 19925645.
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
30. Database of Genomic Variants. , http://projects.tcag.ca/variation/
31. UCSC Genome Browser. , http://genome.ucsc.edu/
32. BioMart. , http://www.ensembl.org/biomart/martview/a4c96f57a539d313f74223bb4719aedf
33. Gene Ontology Tree Machine software, Gene Set Analysis Toolkit version 2. , http://bioinfo.vanderbilt.edu/webgestalt/
34. Zhang B, Schmoyer D, Kirov S, Snoddy J. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics 2004, 5:16. 10.1186/1471-2105-5-16, 373441, 14975175.
35. Jakobsson M, Scholz SW, Scheet P, Gibbs JR, VanLiere JM, Fung HC, Szpiech ZA, Degnan JH, Wang K, Guerreiro R, Bras JM, Schymick JC, Hernandez DG, Traynor BJ, Simon-Sanchez J, Matarin M, Britton A, van de Leemput J, Rafferty I, Bucan M, Cann HM, Hardy JA, Rosenberg NA, Singleton AB. Genotype, haplotype and copy-number variation in worldwide human populations. Nature 2008, 451:998-1003. 10.1038/nature06742, 18288195.
36. Perry GH, Ben-Dor A, Tsalenko A, Sampas N, Rodriguez-Revenga L, Tran CW, Scheffer A, Steinfeld I, Tsang P, Yamada NA, Park HS, Kim JI, Seo JS, Yakhini Z, Laderman S, Bruhn L, Lee C. The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet 2008, 82:685-695. 10.1016/j.ajhg.2007.12.010, 2661628, 18304495.
37. Pinto D, Darvishi K, Shi X, Rajan D, Rigler D, Fitzgerald T, Lionel AC, Thiruvahindrapuram B, MacDonald JR, Mills R, Prasad A, Noonan K, Gribble S, Prigmore E, Donahoe PK, Smith RS, Park JH, Hurles ME, Carter NP, Lee C, Scherer SW, Feuk L. Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol 2011, 29:512-520. 10.1038/nbt.1852, 3270583, 21552272.
38. White SJ, Vissers LE, Geurts van Kessel A, de Menezes RX, Kalay E, Lehesjoki AE, Giordano PC, van de Vosse E, Breuning MH, Brunner HG, den Dunnen JT, Veltman JA. Variation of CNV distribution in five different ethnic populations. Cytogenet Genome Res 2007, 118:19-30. 10.1159/000106437, 17901696.
39. Mkrtchyan H, Gross M, Hinreiner S, Polytiko A, Manvelyan M, Mrasek K, Kosyakova N, Ewers E, Nelle H, Liehr T, Bhatt S, Thoma K, Gebhart E, Wilhelm S, Fahsold R, Volleth M, Weise A. The human genome puzzle: the role of copy number variation in somatic mosaicism. Curr Genomics 2010, 11:426-431. 10.2174/138920210793176047, 3018723, 21358987.
40. Shlien A, Malkin D. Copy number variations and cancer susceptibility. Curr Opin Oncol 2010, 22:55-63. 10.1097/CCO.0b013e328333dca4, 19952747.
41. Korbel JO, Urban AE, Grubert F, Du J, Royce TE, Starr P, Zhong G, Emanuel BS, Weissman SM, Snyder M, Gerstein MB. Systematic prediction and validation of breakpoints associated with copy-number variants in the human genome. Proc Natl Acad Sci USA 2007, 104:10110-10115. 10.1073/pnas.0703834104, 1891248, 17551006.
42. Yoshihara K, Tajima A, Adachi S, Quan J, Sekine M, Kase H, Yahata T, Inoue I, Tanaka K. Germline copy number variations in BRCA1-associated ovarian cancer patients. Genes Chromosomes Cancer 2011, 50:167-177. 10.1002/gcc.20841, 21213370.
43. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massagué J. Genes that mediate breast cancer metastasis to the brain. Nature 2009, 459:1005-1009. 10.1038/nature08021, 2698953, 19421193.
44. Clifford RJ, Zhang J, Meerzaman DM, Lyu MS, Hu Y, Cultraro CM, Finney RP, Kelley JM, Efroni S, Greenblum SI, Nguyen CV, Rowe WL, Sharma S, Wu G, Yan C, Zhang H, Chung YH, Kim JA, Park NH, Song IH, Buetow KH. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology 2010, 52:2034-2043. 10.1002/hep.23943, 21105107.
45. Tse KP, Su WH, Yang ML, Cheng HY, Tsang NM, Chang KP, Hao SP, Yao SY, Chang YS. A gender-specific association of CNV at 6p21.3 with NPC susceptibility. Hum Mol Genet 2011, 20:2889-2896. 10.1093/hmg/ddr191, 21536588.